Coronary artery disease in women Artykuł przeglądowy
##plugins.themes.bootstrap3.article.sidebar##
Opublikowane:
gru 31, 2016
Słowa kluczowe:
coronary artery disease, risk factors, women
##plugins.themes.bootstrap3.article.main##
Abstrakt
Coronary artery disease (CAD) is the leading cause of death both in men and in women. An increasing body of evidence suggests that there are significant differences in the pathophysiology, presentation, optimal diagnostic strategies and therapeutic procedures between women and men with CAD. A lot of common risk factors are claimed to have greater impact on the development of CAD in women. Active diagnostics and effective treatment of psychiatric disorders in women is also very important. Less specific symptoms manifested by women, a higher baseline risk of complications because of their older age and comorbidities, underestimation of the female cardiovascular risk, and following guidelines based on the research conducted on men all result in worse prognosis in women than in men with CAD. The article aims to present the current knowledge about sex and gender differences in CAD, demonstrating the areas that require further research, and underlining the need for increased doctors’ awareness of the different course of CAD in women.
##plugins.themes.bootstrap3.article.details##
Jak cytować
Niedziela, M., Wojciechowska, M., Mamcarz , A., & Cudnoch-Jędrzejewska, A. (2016). Coronary artery disease in women. Medycyna Faktów , 9(4(33), 340-343. Pobrano z https://journalsmededu.pl/index.php/jebm/article/view/2209
Numer
Dział
Artykuły
Copyright © by Medical Education. All rights reserved.
Bibliografia
1. Nichols M, Townsend N, Scarborough P et al. Cardiovascular disease in Europe 2014: epidemiological update. Eur Heart J 2014; 35: 2950-2959.
2. Montalescot G, Sechtem U, Achenbach S et al. 2013 ESC Guidelines on the Management of Stable Coronary Artery Disease. Kardiol Pol 2013; 71: 243-318.
3. Manson JE, Hesia J, Johnson KC et al. Estrogen plus progestin and the risk of coronary heart disease. N Engl J Med 2003; 349: 523-534.
4. Boardman HMP, Hartley L, Eisinga A et al. Hormone therapy for preventing cardiovascular disease in post-menopausal women. Cochrane Database Syst Rev 2015; 3: CD002229 [doi: 10.1002/14651858.CD002229.pub4].
5. Regitz-Zagrosek V, Oertelt-Prigione S, Prescott E et al. Gender in cardiovascular diseases: impact on clinical manifestations, management, and outcomes. Eur Heart J 2016; 37: 24-34.
6. Yusuf S, Hawken S, Ounpuu S et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004; 364: 937-952.
7. Prescott E, Hippe M, Schnohr P et al. Smoking and risk of myocardial infarction in women and men: longitudinal population study. BMJ 1998; 316: 1043-1047.
8. Kotseva K, Wood D, De Backer G et al; for the EUROASPIRE Study Group. Cardiovascular prevention guidelines in daily practice: a comparison of EUROASPIRE I, II, and III surveys in eight European countries. Lancet 2009; 373: 929-940.
9. Huxley R, Barzi F, Woodward M. Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies. BMJ 2006; 332: 73-78.
10. Whooley MA, de Jonge P, Vittinghoff E et al. Depressive symptoms, health behaviors, and risk of cardiovascular events in patients with coronary heart disease. JAMA 2008; 300: 2379-2388.
11. Petitti DB, Sidney S, Quesenberry CP. Oral contraceptive use and myocardial infarction. Contraception 1998; 57: 143-155.
12. Shufelt CL, Bairey Merz CN. Contraceptive hormone use and cardiovascular disease. J Am Coll Cardiol 2009; 53: 221-231.
13. ACOG practice bulletin No73. Use of hormonal contraception in women with coexisting medical conditions. Obstet Gynecol 2006; 107: 1453-1472.
14. D’Antono B, Dupuis G, Fortin C et al. Angina symptoms in men and women with stable coronary artery disease and evidence of exercise-induced myocardial perfusion defects. Am Heart J 2006; 151: 813-819.
15. Redberg RF, Shaw LJ. Diagnosis of coronary artery disease in women. Prog Cardiovasc Dis 2003; 46: 239-258.
16. Shaw LJ, Sharaf BL, Johnson BD et al. The economic burden of angina in women with suspected ischemic heart disease: Results from the National Institutes of Health – National Heart, Lung, and Blood Institute – Sponsored Women’s Ischemia Syndrome Evaluation (WISE). Circulation 2006; 114: 894-904.
17. Mosca L, Linfante AH, Benjamin EJ et al. National study of physician awareness and adherence to cardiovascular disease prevention guidelines. Circulation 2005; 111: 499-510.
18. Healy B. The Yentl syndrome. N Engl J Med 1991; 325: 274-276.
19. Heer T, Hochadel M, Schmidt K et al. Gender differences in therapeutic recommendation after diagnostic coronary angiography: insights from the Coronary Angiography and PCI Registry of the German Society of Cardiology. Clin Res Cardiol 2015; 104: 507-517.
20. Mieres JH, Gulati M, Bairey Merz N et al. Role of noninvasive testing in the clinical evaluation of women with suspected ischemic heart disease: a consensus statement from the American Heart Association. Circulation 2014; 130: 350-379.
21. Ahmed B, Dauerman HL. Women, bleeding, and coronary intervention. Circulation 2013; 127(5): 641-649.
22. Park DW, Kim YH, Yun SC et al. Frequency, causes, predictors, and clinical significance of peri-procedural myocardial infarction following percutaneous coronary intervention. Eur Heart J 2013; 34: 1662-1669.
23. Bukkapatnam RN, Yeo KK, Li Z et al. Operative mortality in women and men undergoing coronary artery bypass grafting (from the California Coronary Artery Bypass Grafting Outcomes Reporting Program). Am J Cardiol 2010; 105: 339-342.
24. Lehmkuhl E, Kendel F, Gelbrich G et al. Gender-specific predictors of early mortality after coronary artery bypass graft surgery. Clin Res Cardiol 2012; 101: 745-751.
25. Gijsberts CM, Agostoni P, Hoefer IE et al. Gender differences in health-related quality of life in patients undergoing coronary angiography. Open Heart 2015; 2: e000231.
2. Montalescot G, Sechtem U, Achenbach S et al. 2013 ESC Guidelines on the Management of Stable Coronary Artery Disease. Kardiol Pol 2013; 71: 243-318.
3. Manson JE, Hesia J, Johnson KC et al. Estrogen plus progestin and the risk of coronary heart disease. N Engl J Med 2003; 349: 523-534.
4. Boardman HMP, Hartley L, Eisinga A et al. Hormone therapy for preventing cardiovascular disease in post-menopausal women. Cochrane Database Syst Rev 2015; 3: CD002229 [doi: 10.1002/14651858.CD002229.pub4].
5. Regitz-Zagrosek V, Oertelt-Prigione S, Prescott E et al. Gender in cardiovascular diseases: impact on clinical manifestations, management, and outcomes. Eur Heart J 2016; 37: 24-34.
6. Yusuf S, Hawken S, Ounpuu S et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004; 364: 937-952.
7. Prescott E, Hippe M, Schnohr P et al. Smoking and risk of myocardial infarction in women and men: longitudinal population study. BMJ 1998; 316: 1043-1047.
8. Kotseva K, Wood D, De Backer G et al; for the EUROASPIRE Study Group. Cardiovascular prevention guidelines in daily practice: a comparison of EUROASPIRE I, II, and III surveys in eight European countries. Lancet 2009; 373: 929-940.
9. Huxley R, Barzi F, Woodward M. Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies. BMJ 2006; 332: 73-78.
10. Whooley MA, de Jonge P, Vittinghoff E et al. Depressive symptoms, health behaviors, and risk of cardiovascular events in patients with coronary heart disease. JAMA 2008; 300: 2379-2388.
11. Petitti DB, Sidney S, Quesenberry CP. Oral contraceptive use and myocardial infarction. Contraception 1998; 57: 143-155.
12. Shufelt CL, Bairey Merz CN. Contraceptive hormone use and cardiovascular disease. J Am Coll Cardiol 2009; 53: 221-231.
13. ACOG practice bulletin No73. Use of hormonal contraception in women with coexisting medical conditions. Obstet Gynecol 2006; 107: 1453-1472.
14. D’Antono B, Dupuis G, Fortin C et al. Angina symptoms in men and women with stable coronary artery disease and evidence of exercise-induced myocardial perfusion defects. Am Heart J 2006; 151: 813-819.
15. Redberg RF, Shaw LJ. Diagnosis of coronary artery disease in women. Prog Cardiovasc Dis 2003; 46: 239-258.
16. Shaw LJ, Sharaf BL, Johnson BD et al. The economic burden of angina in women with suspected ischemic heart disease: Results from the National Institutes of Health – National Heart, Lung, and Blood Institute – Sponsored Women’s Ischemia Syndrome Evaluation (WISE). Circulation 2006; 114: 894-904.
17. Mosca L, Linfante AH, Benjamin EJ et al. National study of physician awareness and adherence to cardiovascular disease prevention guidelines. Circulation 2005; 111: 499-510.
18. Healy B. The Yentl syndrome. N Engl J Med 1991; 325: 274-276.
19. Heer T, Hochadel M, Schmidt K et al. Gender differences in therapeutic recommendation after diagnostic coronary angiography: insights from the Coronary Angiography and PCI Registry of the German Society of Cardiology. Clin Res Cardiol 2015; 104: 507-517.
20. Mieres JH, Gulati M, Bairey Merz N et al. Role of noninvasive testing in the clinical evaluation of women with suspected ischemic heart disease: a consensus statement from the American Heart Association. Circulation 2014; 130: 350-379.
21. Ahmed B, Dauerman HL. Women, bleeding, and coronary intervention. Circulation 2013; 127(5): 641-649.
22. Park DW, Kim YH, Yun SC et al. Frequency, causes, predictors, and clinical significance of peri-procedural myocardial infarction following percutaneous coronary intervention. Eur Heart J 2013; 34: 1662-1669.
23. Bukkapatnam RN, Yeo KK, Li Z et al. Operative mortality in women and men undergoing coronary artery bypass grafting (from the California Coronary Artery Bypass Grafting Outcomes Reporting Program). Am J Cardiol 2010; 105: 339-342.
24. Lehmkuhl E, Kendel F, Gelbrich G et al. Gender-specific predictors of early mortality after coronary artery bypass graft surgery. Clin Res Cardiol 2012; 101: 745-751.
25. Gijsberts CM, Agostoni P, Hoefer IE et al. Gender differences in health-related quality of life in patients undergoing coronary angiography. Open Heart 2015; 2: e000231.